174 related articles for article (PubMed ID: 6436701)
1. Hormonal therapy for prostate cancer.
Torti FM
N Engl J Med; 1984 Nov; 311(20):1313-4. PubMed ID: 6436701
[No Abstract] [Full Text] [Related]
2. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate.
Garnick MB; Glode LM; Smith JA; Max DT
Br J Clin Pract; 1985 Feb; 39(2):73-6. PubMed ID: 3921047
[No Abstract] [Full Text] [Related]
3. Leuprolide versus diethylstilbestrol for previously untreated stage D2 prostate cancer. Results of a prospectively randomized trial.
Garnick MB
Urology; 1986 Jan; 27(1 Suppl):21-8. PubMed ID: 3079935
[TBL] [Abstract][Full Text] [Related]
4. LHRH analogues in the treatment of prostatic cancer. Introduction.
Dufour B
Br J Clin Pract Suppl; 1985 Mar; 37():2-3, 14-5. PubMed ID: 3931663
[No Abstract] [Full Text] [Related]
5. Combined androgen blockade: leuprolide and flutamide versus leuprolide and placebo.
Crawford ED; Goodman P; Blumenstein B
Semin Urol; 1990 Aug; 8(3):154-8. PubMed ID: 2119048
[No Abstract] [Full Text] [Related]
6. Evaluation of synthetic agonist analogue of gonadotropin-releasing hormone (leuprolide) on testicular androgen production in patients with carcinoma of prostate.
Santen RJ; Warner B
Urology; 1985 Feb; 25(2 Suppl):53-7. PubMed ID: 3918377
[TBL] [Abstract][Full Text] [Related]
7. Management of metastatic prostatic cancer.
Paulson DF
Urology; 1985 Feb; 25(2 Suppl):49-52. PubMed ID: 3918376
[TBL] [Abstract][Full Text] [Related]
8. Hormonal therapy of prostatic cancer.
Brendler CB
J Urol; 1985 Apr; 133(4):650-1. PubMed ID: 3920407
[No Abstract] [Full Text] [Related]
9. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate.
Garnick MB; Glode LM; Smith JA; Max DT
Br J Clin Pract Suppl; 1985 Mar; 37():8-12, 20-4. PubMed ID: 3931665
[No Abstract] [Full Text] [Related]
10. Management of newly diagnosed metastatic carcinoma of the prostate.
Elder JS; Catalona WJ
Urol Clin North Am; 1984 May; 11(2):283-95. PubMed ID: 6428022
[TBL] [Abstract][Full Text] [Related]
11. Initiation of LHRH monotherapy for prostate cancer.
Milsted RA
Prog Clin Biol Res; 1989; 303():69-74. PubMed ID: 2528742
[No Abstract] [Full Text] [Related]
12. Luteinizing hormone-releasing hormone (LH-RH) analogs in treatment of prostatic cancer. Clinical perspective.
Smith JA
Urology; 1986 Jan; 27(1 Suppl):9-15. PubMed ID: 3079936
[TBL] [Abstract][Full Text] [Related]
13. Treatment of metastatic carcinoma of the prostate with leuprolide, an LHRH analogue.
Smith JA
Prog Clin Biol Res; 1985; 185A():279-85. PubMed ID: 3929267
[No Abstract] [Full Text] [Related]
14. Leuprolide versus diethylstilbestrol for metastatic prostate cancer.
Leuprolide Study Group
N Engl J Med; 1984 Nov; 311(20):1281-6. PubMed ID: 6436700
[TBL] [Abstract][Full Text] [Related]
15. Clinical effects of gonadotropin-releasing hormone analogue in metastatic carcinoma of prostate.
Smith JA; Glode LM; Wettlaufer JN; Stein BS; Glass AG; Max DT; Anbar D; Jagst CL; Murphy GP
Urology; 1985 Feb; 25(2):106-14. PubMed ID: 3918369
[TBL] [Abstract][Full Text] [Related]
16. [New hormonal treatments of metastatic prostatic cancer. Review of the literature].
Dubost JJ; Sauvezie B; Ristori JM; Thevenet JP; Rampon S
Rev Rhum Mal Osteoartic; 1985 Oct; 52(10):577-85. PubMed ID: 3909364
[No Abstract] [Full Text] [Related]
17. Phase III studies in prostatic cancer with leuprolide acetate.
Seely JH
J Androl; 1987; 8(1):S23-6. PubMed ID: 3104263
[No Abstract] [Full Text] [Related]
18. Clinical progress with LHRH analogues in prostatic cancer. Proceedings of an international symposium. Monte Carlo, 20 January 1990.
J Int Med Res; 1990; 18 Suppl 1():1-125. PubMed ID: 2108881
[No Abstract] [Full Text] [Related]
19. Leuprolide: a review of its effects in animals and man.
Drago JR; Rohner T; Santen R; Manni A; English H; Lipton A; Harvey H
Br J Clin Pract; 1985 Feb; 39(2):77-9. PubMed ID: 3921048
[No Abstract] [Full Text] [Related]
20. [LHRH analogs--new possibilities in the treatment of prostatic cancer].
Baranowska B
Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):1009-12. PubMed ID: 6239145
[No Abstract] [Full Text] [Related]
[Next] [New Search]
